|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA I/II (Lead Monitor Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
08.18 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
08.18 |
|
|
(ÁÖ)³×ºñÆÊ |
½ÃÇè°Ë»ç±â°ü Á÷¿ø ¸ðÁý
°æ±â ¼ö¿ø½Ã Àå¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
08.17 |
|
|
À£Æ®ÁÖ½Äȸ»ç |
ÀÓ»ó½ÃÇè ¸Å´ÏÀú (Clinical Research Manager)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
»ó½Ãä¿ë |
08.13 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSD] MSL-ID/Vaccine
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSDµ¿¹°¾àÇ°]-Technical Marketing Manager-¹Ý·Áµ¿¹°,
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSDµ¿¹°¾àÇ°]¾çµ· Marketing Manager
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
08.13 |
|
|
(ÁÖ)´Ù¸²½áÁö³Ý |
»ý»êÁ÷/Áֺλç¿ø ¿ì´ë ÀÇ·á±â±â »ç¿ø ¸ðÁý
¼¿ï °¼±¸ | Çз¹«°ü |
»ý»ê/»ý»ê°ü¸® |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.12 |
|
|
ÁÖ½Äȸ»ç Ç층½º |
Àӻ󿬱¸º»ºÎ DMÆÀ ÆÀÀå ä¿ë(Â÷Àå±Þ ÀÌ»ó)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
7³â¡è |
ä¿ë½Ã |
08.10 |
|
|
¢ß´Ù»êÁ¦¾à |
Ç°Áú°ü¸®ÆÀ Á¦Ç° ÆÄÆ®
Ãæ³² ¾Æ»ê½Ã | Çз¹«°ü |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.10 |
|
|
¾ÆÇǸÞÁî |
ÀǾàÇ° ºÐ¼®¿¬±¸ ÆÀ¿ø ä¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
08.09 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) ä¿ë_»ýµ¿BD °æ·ÂÀÚ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
08.03 |
|
|
¢ß´Ù»êÁ¦¾à |
Ç°Áúº¸ÁõÆÀ °è¾àÁ÷ ä¿ë
Ãæ³² ¾Æ»ê½Ã | °íµîÇб³ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.02 |
|
|
±¸ÁÖÁ¦¾à(ÁÖ) |
°íÇüÁ¦ÆÀ ´ã´çÀÚ Ã¤¿ëÇÕ´Ï´Ù.(°æ·Â)
°æ±â ȼº½Ã | °íµîÇб³ |
»ý»ê/»ý»ê°ü¸® |
3³â¡è |
ä¿ë½Ã |
07.30 |
|